Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $493.9 million.

  • GeneDx Holdings' Liabilities and Shareholders Equity rose 2080.57% to $493.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year increase of 1317.95%. This contributed to the annual value of $419.4 million for FY2024, which is 14.9% up from last year.
  • As of Q3 2025, GeneDx Holdings' Liabilities and Shareholders Equity stood at $493.9 million, which was up 2080.57% from $463.9 million recorded in Q2 2025.
  • GeneDx Holdings' 5-year Liabilities and Shareholders Equity high stood at $933.3 million for Q2 2022, and its period low was $175.5 million during Q2 2021.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $463.9 million (2025), whereas its average is $484.0 million.
  • In the last 5 years, GeneDx Holdings' Liabilities and Shareholders Equity surged by 43168.35% in 2022 and then tumbled by 4966.25% in 2023.
  • Quarter analysis of 5 years shows GeneDx Holdings' Liabilities and Shareholders Equity stood at $554.1 million in 2021, then dropped by 11.4% to $490.9 million in 2022, then dropped by 14.7% to $418.8 million in 2023, then increased by 0.15% to $419.4 million in 2024, then increased by 17.77% to $493.9 million in 2025.
  • Its Liabilities and Shareholders Equity was $493.9 million in Q3 2025, compared to $463.9 million in Q2 2025 and $446.4 million in Q1 2025.